Arkolith/Insider Trading/PCSA/Form 4

Skibsted Russell

Chief Financial OfficerProcessa Pharmaceuticals, Inc. (PCSA) · full profile →Form 4 · filed Jun 16, 2026
Net Buying
Open-Market Buys
$6K
Open-Market Sells
$0
Net Open-Market Flow
$6K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 15, 2026Buy(P)3K$2.22$6K13K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000897069-26-001412) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML